BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 24905637)

  • 1. Linkage of a de-identified United States rheumatoid arthritis registry with administrative data to facilitate comparative effectiveness research.
    Curtis JR; Chen L; Bharat A; Delzell E; Greenberg JD; Harrold L; Kremer J; Setoguchi S; Solomon DH; Xie F; Yun H
    Arthritis Care Res (Hoboken); 2014 Dec; 66(12):1790-8. PubMed ID: 24905637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of health plan combined with registry data to predict clinical trial recruitment.
    Curtis JR; Wright NC; Xie F; Chen L; Zhang J; Saag KG; Bharat A; Kremer J; Cofield S; Winthrop K; Delzell E
    Clin Trials; 2014 Feb; 11(1):96-101. PubMed ID: 24346611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methodological Challenges When Comparing Demographic and Clinical Characteristics of International Observational Registries.
    Verstappen SM; Askling J; Berglind N; Franzen S; Frisell T; Garwood C; Greenberg JD; Holmqvist M; Horne L; Lampl K; Michaud K; Nyberg F; Pappas DA; Reed G; Symmons DP; Tanaka E; Tran TN; Yamanaka H; Ho M
    Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1637-45. PubMed ID: 26201948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can rheumatoid arthritis (RA) registries provide contextual safety data for modern RA clinical trials? The case for mortality and cardiovascular disease.
    Michaud K; Berglind N; Franzén S; Frisell T; Garwood C; Greenberg JD; Ho M; Holmqvist M; Horne L; Inoue E; Nyberg F; Pappas DA; Reed G; Symmons D; Tanaka E; Tran TN; Verstappen SM; Wesby-van Swaay E; Yamanaka H; Askling J
    Ann Rheum Dis; 2016 Oct; 75(10):1797-805. PubMed ID: 26857699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Design characteristics of the CORRONA CERTAIN study: a comparative effectiveness study of biologic agents for rheumatoid arthritis patients".
    Pappas DA; Kremer JM; Reed G; Greenberg JD; Curtis JR
    BMC Musculoskelet Disord; 2014 Apr; 15():113. PubMed ID: 24690143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and Predictors of Biological Antirheumatic Drug Discontinuation Attempts among Patients with Rheumatoid Arthritis in Remission: A CORRONA and NinJa Collaborative Cohort Study.
    Yoshida K; Radner H; Mjaavatten MD; Greenberg JD; Kavanaugh A; Kishimoto M; Matsui K; Okada M; Reed G; Saeki Y; Tohma S; Kremer J; Solomon DH
    J Rheumatol; 2015 Dec; 42(12):2238-46. PubMed ID: 26523025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease activity and patient-reported outcomes in patients with rheumatoid arthritis and Sjögren's syndrome enrolled in a large observational US registry.
    Harrold LR; Shan Y; Rebello S; Kramer N; Connolly SE; Alemao E; Kelly S; Kremer JM; Rosenstein ED
    Rheumatol Int; 2020 Aug; 40(8):1239-1248. PubMed ID: 32449040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effectiveness and safety of rituximab versus subsequent anti-tumor necrosis factor therapy in patients with rheumatoid arthritis with prior exposure to anti-tumor necrosis factor therapies in the United States Corrona registry.
    Harrold LR; Reed GW; Magner R; Shewade A; John A; Greenberg JD; Kremer JM
    Arthritis Res Ther; 2015 Sep; 17(1):256. PubMed ID: 26382589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of an indirect linkage algorithm to combine registry data with Medicare claims.
    Mao J; Moore KO; Columbo JA; Mehta KS; Goodney PP; Sedrakyan A
    J Vasc Surg; 2022 Jul; 76(1):266-271.e2. PubMed ID: 35181518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Treatment With Biologic Agents on the Use of Mechanical Devices Among Rheumatoid Arthritis Patients in a Large US Patient Registry.
    Strand V; Greenberg JD; Griffith J; Bao Y; Saunders KC; Garg V; Li G; Ganguli A
    Arthritis Care Res (Hoboken); 2016 Jul; 68(7):914-21. PubMed ID: 26555655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using epidemiological registry data to provide background rates as context for adverse events in a rheumatoid arthritis drug development program: a coordinated approach.
    Nyberg F; Askling J; Berglind N; Franzén S; Ho M; Holmqvist M; Horne L; Lampl K; Michaud K; Pappas DA; Reed G; Symmons D; Tanaka E; Tran TN; Verstappen SM; Wesby-van Swaay E; Yamanaka H; Greenberg JD
    Pharmacoepidemiol Drug Saf; 2015 Nov; 24(11):1121-32. PubMed ID: 26303866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linking a Total Ankle Arthroplasty Registry to Medicare Inpatient Claims without Unique Identifiers.
    Raman SR; Hammill BG; Queen RM; Adams SB; Curtis LH
    J Bone Joint Surg Am; 2018 Jun; 100(12):1016-1022. PubMed ID: 29916928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Corrona US registry of rheumatic and autoimmune diseases.
    Kremer JM
    Clin Exp Rheumatol; 2016; 34(5 Suppl 101):S96-S99. PubMed ID: 27762197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design characteristics of the Corrona Japan rheumatoid arthritis registry.
    Yamanaka H; Kishimoto M; Pappas DA; Greenberg JD; Kremer JM; Tanaka Y
    Mod Rheumatol; 2018 Jan; 28(1):95-100. PubMed ID: 28448195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do Patients With Moderate or High Disease Activity Escalate Rheumatoid Arthritis Therapy According to Treat-to-Target Principles? Results From the Rheumatology Informatics System for Effectiveness Registry of the American College of Rheumatology.
    Yun H; Chen L; Xie F; Patel H; Boytsov N; Zhang X; Curtis JR
    Arthritis Care Res (Hoboken); 2020 Feb; 72(2):166-175. PubMed ID: 31566905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CORRONA database.
    Kremer JM
    Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S172-7. PubMed ID: 16273803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Derivation and preliminary validation of an administrative claims-based algorithm for the effectiveness of medications for rheumatoid arthritis.
    Curtis JR; Baddley JW; Yang S; Patkar N; Chen L; Delzell E; Mikuls TR; Saag KG; Singh J; Safford M; Cannon GW
    Arthritis Res Ther; 2011; 13(5):R155. PubMed ID: 21933396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The comparative effectiveness of biologics among older adults and disabled rheumatoid arthritis patients in the Medicare population.
    Yun H; Xie F; Delzell E; Chen L; Yang S; Saag KG; Joseph G; Harrison D; Curtis JR
    Br J Clin Pharmacol; 2015 Dec; 80(6):1447-57. PubMed ID: 26130274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity of deterministic record linkage using multiple indirect personal identifiers: linking a large registry to claims data.
    Setoguchi S; Zhu Y; Jalbert JJ; Williams LA; Chen CY
    Circ Cardiovasc Qual Outcomes; 2014 May; 7(3):475-80. PubMed ID: 24755909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical status and economic savings associated with remission among patients with rheumatoid arthritis: leveraging linked registry and claims data for synergistic insights.
    Curtis JR; Chen L; Greenberg JD; Harrold L; Kilgore ML; Kremer JM; Solomon DH; Yun H
    Pharmacoepidemiol Drug Saf; 2017 Mar; 26(3):310-319. PubMed ID: 28028867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.